2030 年腎造口設備市場預測 - 按產品類型、最終用戶和地區分類的全球分析

根據 Stratistics MRC 的數據，2023 年全球腎造口器材市場規模為 15.050 億美元，預計到 2030 年將達到 28.871 億美元，預測期內年複合成長率為 9.8%。

為了從腎臟排放尿液，需要透過皮膚插入一根稱為腎造口管的細軟性管。此管用於暫時排放阻塞的尿液。在體外，塑膠袋與管子連接以收集體液。腎造口術有助於保持腎臟健康並免受損傷和感染。腎造口術還允許醫生使用超音波、X 光或顯影劑劑注射來觀察輸尿管，這有助於診斷潛在的問題。

據加拿大腎臟基金會稱，腎結石在加拿大很常見，而且發病率似乎呈上升趨勢，尤其是在過去 25年度中。據估計，大約 12% 的男性和 6% 的女性會在一生中的某個階段患上腎結石。

泌尿系統疾病增加

腎臟病、腎結石、閉尿症、膀胱癌、前列腺癌等泌尿系統疾病發生率的增加以及經皮腎造口術治療的增加是預測期內影響市場的主要要素。此外，老年人口更容易患上需要長期照護的慢性病，​​例如失禁、消化困難和慢性病。因此，世界老年人口的成長預計將成為強大的推動力。此外，隨著人口高齡化，泌尿系統手術數量將增加，這將推動市場成長。

產生負面後果

人們常擔心的是腎造口管放置部位的感染。醫療保健專業人員採取預防措施來降低這種風險，包括在治療期間採用無菌程序並指導患者進行適當的護理和維護。腎造口術期間或之後可能會發生出血，這可能發生在特殊情況下，需要額外的醫療照護。有些人對敷料或腎造口管中的成分有過敏反應。當不再需要腎造口管時，移除部位可能會出現輕微出血、不適和疼痛，阻礙市場成長。

微創手術需求不斷成長

對侵入性手術的需求增加以及成功率更高的腎臟造口設備的技術發展等要素將在預測期內推動市場。對於因腎臟阻塞或感染疾病而感到疼痛的患者，腎造口術可以透過減輕腎臟壓力和減少發炎來顯著緩解疼痛。此外，腎臟能夠過濾廢物並繼續維持液體平衡，為市場成長創造了廣泛的機會。

替代技術的可用性

腎造口術替代技術的出現對患者照護既有正面的影響，也有負面的影響。可能會在沒有仔細評估患者的需求和醫療狀況的情況下選擇其他手術，這對患者護理有潛在風險。結果，結果可能不理想或可能出現困難，導致治療不當。多種要素，包括醫療保健專業人員的經驗和資源的可用性，可以極大地影響替代手術的品質。

COVID-19 的影響：

由於全球封鎖導致腎臟病相關手術和諮詢延誤，第一波 COVID-19 對腎臟造口設備市場產生了重大影響。由於缺乏資源和人力，COVID-19 大流行迫使世界各地的泌尿系統部門重組其實踐。然而，隨著法規的放鬆，由於腎臟疾病發病率的增加和腎造口設備的使用增加，預計未來年度市場將擴大。

預計導絲細分市場在預測期內將是最大的

由於導絲段能夠進入並幫助通過各種管腔結構，因此預計將顯著成長。導絲是一種有效的裝置。泌尿系統導絲用於在診斷和介入手術期間方便放置泌尿系統設備。腎結石疾病發生率上升，卵巢、膀胱、前列腺等惡性的頻發，以及微創手術治療需求的增加，導致腎臟問題增多，對微創腎病廠家的需求也隨之增加。瘻管形成過程中對導絲的需求，預計將推動市場擴張。

門診手術中心領域預計在預測期內年複合成長率最高

預計門診手術中心部門在預測期內的年複合成長率最高，因為與醫院和其他醫療機構相比，它提供更個體化的服務並取得更好的成果。此外，ASC 不必處理治療各種疾病和病症的問題，可以確保患者獲得量身定做的護理和更好的患者體驗，從而促進市場成長。

佔比最大的地區：

由於有利的報銷規則、不斷提高的產品知名度、高素質醫生的可用性以及該地區成熟的醫療機構的存在，預計北美在預測期內將佔據最大的市場佔有率。除了技術改進的醫療用品的快速普及外，該地區腎結石患病的上升預計將增加對腎造口設備的需求。

複合年複合成長率最高的地區：

由於醫院、診所和泌尿系統專科中心等醫療保健設施的建立，預計亞太地區在預測期內將出現最高的年複合成長率。這使得需要腎臟造口手術的人更容易獲得醫療保健服務，從而增加了對腎臟造口設備的需求。此外，地方政府正在製定法律並發起配合措施，以升級醫療保健系統並促進尖端醫療技術的使用。這包括泌尿系統手術的報銷計劃和財務援助，推動市場成長。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

• 公司簡介
  • 其他市場參與者的綜合分析（最多 3 家公司）
  • 主要企業SWOT分析（最多3家企業）
• 區域分割
  • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
• 競爭基準化分析
  • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

• 概述
• 利害關係人
• 調查範圍
• 調查方法
  • 資料探勘
  • 資料分析
  • 資料檢驗
  • 研究途徑
• 調查來源
  • 主要調查來源
  • 二次調查來源
  • 先決條件

第3章 市場趨勢分析

• 促進因素
• 抑制因素
• 機會
• 威脅
• 產品分析
• 最終用戶分析
• 新興市場
• 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

• 供應商的議價能力
• 買方議價能力
• 替代品的威脅
• 新進入者的威脅
• 競爭公司之間的敵對關係

第5章 全球腎臟造口設備市場：依產品類型

• 腎造口導管
• 導絲
• 擴張器鞘
• 引流管
• 其他產品類型

第6章 全球腎臟造口設備市場：依最終用戶分類

• 門診手術中心
• 急診室
• 醫院
• 其他最終用戶

第7章 全球腎臟造口設備市場：依地區

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙
  • 其他歐洲國家
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 紐西蘭
  • 韓國
  • 其他亞太地區
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 卡達
  • 南非
  • 其他中東和非洲

第8章 進展

• 合約、夥伴關係、協作和合資企業
• 收購和合併
• 新產品發布
• 業務擴展
• 其他關鍵策略

第9章 公司簡介

• Angiodynamics Inc
• Argon Medical
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health
• Coloplast Group
• Cook Group（Cook Medical Incorporated）
• Envaste Limited
• Medi-Globe GmbH
• Meditech Devices Pvt Ltd
• Olympus Corporation
• Straub Medical AG
• SURU International Pvt. Ltd
• Teleflex Incorporated
• Uresil LLC

According to Stratistics MRC, the Global Nephrostomy Devices Market is accounted for $1500.5 million in 2023 and is expected to reach $2887.1 million by 2030 growing at a CAGR of 9.8% during the forecast period. To drain urine from the kidney, a thin, flexible tube called a nephrostomy tube is inserted through the skin. The tube is utilized to temporarily discharge obstructed pee. A plastic bag is connected to the tube outside the body to collect the fluid. Nephrostomies can help keep the kidneys healthy and shield them from injury and infection. A nephrostomy device can also aid in the diagnosis of an underlying issue since the ureter can be seen using ultrasonography, X-rays, and contrast material injection.

According to the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life.

Market Dynamics:

Driver:

Rising incidence of urological disorders

Increased incidence of urological conditions such as hydronephrosis, kidney stones, urine retention, bladder cancer, and prostate cancer and the rise in percutaneous nephrostomy treatments are the main factors impacting the market throughout the projected period. Furthermore, the geriatric population is more susceptible to chronic illnesses that need long-term care, such as incontinence, digestive difficulties, and chronic ailments. Therefore, a high-impact driver is anticipated to be an increase in the world's senior population. Additionally, the number of urological procedures performed will climb along with the aging population, which drives market growth.

Restraint:

Entailing negative outcomes

One frequent concern is infection at the location where the nephrostomy tube is placed. Healthcare professionals take preventative measures to reduce this risk, including employing sterile procedures during the treatment and giving patients the right care and maintenance instructions. During or after the nephrostomy surgery, bleeding is possible, which can happen in exceptional circumstances and call for additional medical attention. Some individuals may experience an allergic response to the components of the dressing or nephrostomy tube. There may be slight bleeding, discomfort, or pain at the removal site when the nephrostomy tube is no longer required, thus hampering the growth of the market.

Opportunity:

Rise in demand for minimal invasive operations

Over the course of the forecast period, factors like a rise in demand for less invasive operations and technical developments in nephrostomy devices with a high success rate will drive the market. For patients experiencing pain due to kidney obstruction or infections, a nephrostomy can provide significant pain relief by alleviating the pressure and reducing inflammation in the kidney. It also allows the kidney to continue filtering waste and maintaining fluid balance, creating a wide range of opportunities for market growth.

Threat:

Availability of alternative procedures

The availability of alternatives to nephrostomy surgery can affect patient care in both positive and negative ways, as different procedures may be chosen without a careful assessment of the patient's needs and medical condition, which carries both potential risks for their care. This may result in the decision to take an unsuitable course of action, which may provide less than ideal results or cause difficulties. Various factors, including the experience of the healthcare professional and the accessibility of resources, can have a significant impact on the quality of alternative operations.

COVID-19 Impact:

The initial wave of COVID-19 had a substantial influence on the market for nephrostomy devices because of the delays in nephrology-related procedures and consultations brought on by the global lockdown. The COVID-19 outbreak forced urology departments worldwide to restructure care owing to insufficient resources and manpower. However, as the regulations are loosened, the market is anticipated to expand in the years to come as a result of the rise in renal disorders and the increased use of nephrostomy devices.

The guidewires segment is expected to be the largest during the forecast period

The guidewires segment is estimated to have significant growth because of its ability to gain access and aid transit across different luminal structures. A guidewire is an effective instrument. To make the placement of endourological tools during diagnostic or interventional procedures easier, urological guidewires are used. Due to the rise in renal issues and the desire for minimally invasive kidney disease manufacturers, the rising incidence of kidney stone disorders, the frequency of ovarian, bladder, and prostate malignancies, and the rising desire for less invasive surgical treatments are anticipated to raise the need for guidewires during nephrostomy procedures, which is predicted to encourage market expansion.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgical centers segment is anticipated to witness the highest CAGR during the forecast period, as they provide more individualized services and greater results in comparison to hospitals and other healthcare settings. Additionally, ASCs do not have to deal with the issue of treating a variety of diseases and disorders; they can guarantee that patients receive tailored attention with a better patient experience, thus enhancing the growth of the market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the advantageous reimbursement rules, rising product awareness, the availability of highly qualified physicians, and the existence of established healthcare facilities in the area. In addition to the rapid use of technologically improved medical goods, the rise in the prevalence of kidney stones in the region is expected to increase the demand for nephrostomy devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the establishment of medical facilities such as hospitals, clinics, and urology specialty centers. This raises the need for nephrostomy devices by making healthcare services more accessible to those who need nephrostomy surgeries. Additionally, regional governments are enacting laws and launching efforts to upgrade the healthcare system and promote the use of cutting-edge medical technologies. This covers reimbursement plans and financial aid for urological procedures, thus propelling the growth of the market.

Key players in the market:

Some of the key players profiled in the Nephrostomy Devices Market include: Angiodynamics Inc, Argon Medical, B. Braun Melsungen AG., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Group (Cook Medical Incorporated), Envaste Limited, Medi-Globe GmbH, Meditech Devices Pvt Ltd, Olympus Corporation, Straub Medical AG, SURU International Pvt. Ltd, Teleflex Incorporated and Uresil LLC

Key Developments:

In August 2023, Cardinal health launches next generation medical device to improve neonatal feeding, through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills.

In June 2023, Becton, Dickinson and Company a leading global medical technology company, announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS for $540 million.

In May 2023, Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument. The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue sample.

Product Types Covered:

• Nephrostomy Catheters
• Guidewires
• Dilators Sheaths
• Drainage Tubes
• Other Product Types

End Users Covered:

• Ambulatory Surgical Centers
• Emergency Clinics
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Nephrostomy Devices Market, By Product Type

• 5.1 Introduction
• 5.2 Nephrostomy Catheters
• 5.3 Guidewires
• 5.4 Dilators Sheaths
• 5.5 Drainage Tubes
• 5.6 Other Product Types

6 Global Nephrostomy Devices Market, By End User

• 6.1 Introduction
• 6.2 Ambulatory Surgical Centers
• 6.3 Emergency Clinics
• 6.4 Hospitals
• 6.5 Other End Users

7 Global Nephrostomy Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Angiodynamics Inc
• 9.2 Argon Medical
• 9.3 B. Braun Melsungen AG
• 9.4 Becton, Dickinson and Company
• 9.5 Boston Scientific Corporation
• 9.6 Cardinal Health
• 9.7 Coloplast Group
• 9.8 Cook Group (Cook Medical Incorporated)
• 9.9 Envaste Limited
• 9.10 Medi-Globe GmbH
• 9.11 Meditech Devices Pvt Ltd
• 9.12 Olympus Corporation
• 9.13 Straub Medical AG
• 9.14 SURU International Pvt. Ltd
• 9.15 Teleflex Incorporated
• 9.16 Uresil LLC

List of Tables

• Table 1 Global Nephrostomy Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 3 Global Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 4 Global Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 5 Global Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 6 Global Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 7 Global Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 8 Global Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 9 Global Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 10 Global Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 11 Global Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 12 Global Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 13 North America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 14 North America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 15 North America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 16 North America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 17 North America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 18 North America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 19 North America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 20 North America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 21 North America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 22 North America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 23 North America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 24 North America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 25 Europe Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 26 Europe Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 27 Europe Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 28 Europe Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 29 Europe Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 30 Europe Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 31 Europe Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 32 Europe Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 33 Europe Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 34 Europe Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 35 Europe Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 36 Europe Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 37 Asia Pacific Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 38 Asia Pacific Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 39 Asia Pacific Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 40 Asia Pacific Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 41 Asia Pacific Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 42 Asia Pacific Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 43 Asia Pacific Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 44 Asia Pacific Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 45 Asia Pacific Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 46 Asia Pacific Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 47 Asia Pacific Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 48 Asia Pacific Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 49 South America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 50 South America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 51 South America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 52 South America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 53 South America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 54 South America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 55 South America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 56 South America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 57 South America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 58 South America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 59 South America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 60 South America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 Middle East & Africa Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Middle East & Africa Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
• Table 63 Middle East & Africa Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
• Table 64 Middle East & Africa Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
• Table 65 Middle East & Africa Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
• Table 66 Middle East & Africa Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
• Table 67 Middle East & Africa Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 68 Middle East & Africa Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 69 Middle East & Africa Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 70 Middle East & Africa Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
• Table 71 Middle East & Africa Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 72 Middle East & Africa Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)